Advancement in Sutures to Drive Global Hospital Suture Market

According to our new research study on "Hospital Suture Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product, Nature, Type, and Application," the market is expected to grow from US$ 3,649.02 million in 2021 to US$ 5,495.74 million by 2028; it is estimated to grow at a CAGR of 6.0% from 2021 to 2028. Factors driving the hospital suture market's growth are the advancements in sutures and increasing cases of chronic wounds. However, the noninvasive alternatives to stitches can hamper the hospital suture market's growth.

The development of innovative surgical techniques and an increasing number of surgeries are expected to grow the hospital sutures market. The rising accident and trauma cases and the growing pervasiveness of various severe disorders have created significant demand for hospital sutures across healthcare settings. Surgeons use these surgical devices to close wounds on the patients' skin or other tissues, crucial for wound healing. According to the World Health Organization (WHO), ~1.3 million people die in road accidents every year, whereas ~20-50 million people suffer nonfatal injuries. An increasing number of patients signing up for knee & hip replacement, hysterectomy, bypass operation, and cosmetic & plastic surgeries increase the demand for hospital suture devices to fix the injuries rapidly. For example, according to a report published by HEALTHLINE MEDIA, ~600,000 knee replacement operations are executed annually in the US. As per the records by Texas Heart Institute, ~200,000 coronary artery bypass graft operations are accomplished yearly in the country. Also, various product approvals will drive the hospital suture market. For instance, in December 2020, Apollo Endosurgery, Inc., was granted the US Food and Drug Administration (FDA) sanction of the X-Tack Endoscopic HeliX appending system to expand its usage.

Assut Medical SARL, Boston Scientific, W.L Gore and Associates, Medtronic, Johnson and Johnson Medical N.V., B. Braun Melsungen AG, Smith and Nephew, Serag-Wiessner GMBH and Co. KG, Teleflex Medical OEM, and Demtech Corporation are the leading companies operating in the hospital suture market.

Based on product, the hospital suture market is segmented into sutures, automated suturing devices, and others. Based on nature, the market is bifurcated into absorbable sutures and non-absorbable sutures. Based on type, the hospital suture market is bifurcated into monofilament and braided. Based on application, the market is segmented into general surgery, orthopedic surgery, cardiovascular surgery, and others. By geography, the hospital suture market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com